Patatin-Like phospholipase Domain Containing 2 (PNPLA2) (Middle Region) Peptide
PNPLA2
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all PNPLA2 products
- PNPLA2 (Patatin-Like phospholipase Domain Containing 2 (PNPLA2))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- RDGLRFLQRN GLLNRPNPLL ALPPARPHGP EDKDQAVESA QAEDYSQLPG
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PNPLA2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PNPLA2 (Patatin-Like phospholipase Domain Containing 2 (PNPLA2))
- Background
-
This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy.
Alias Symbols: 1110001C14Rik, ATGL, DESNUTRIN, DKFZp667M109, FP17548, PEDF-R, TTS-2.2, TTS2
Protein Interaction Partner: MARK3,PHYHIP,SMAD9,MARK3,PHYHIP,UBE2R2
Protein Size: 504 - Molecular Weight
- 55 kDa
- Gene ID
- 57104
- NCBI Accession
- NM_020376, NP_065109
- UniProt
- Q96AD5
-
You are here:
